Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
Beta Drugs Ltd - Updates     Back
(22 Nov 2024)
Beta Drugs Limited has informed the Exchange regarding the Board meeting to be held on 27th november, 2024 to interalia, transact the following business:-1. To consider & approve the allotment of 100 fully paid-up equity shares of the Company of face value of Rs. 10 each, at a price of Rs 1,653.40 per Equity Share including a premium of Rs. 1,643.40 per Equity Share and 7,07,651 fully paid up unsecured compulsory convertible debentures of the Company ( CCDs ) of face value of Rs. 1,653.40 each under Preferential Issue, pursuant to approval obtained from shareholders in Extra Ordinary General Meeting held on 12th November, 2024.2. To consider, approve & adopt the restated Article of Association of the company, subject to the approval of shareholders of the company in their meeting..
Top